Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
US GoldMining
USGO
$106M
| $91K | ﹤0.01% |
+10,571
| New | +$106K |
|
3302
Traws Pharma
TRAW
$6.85M
| $89.3K | ﹤0.01% |
+10,052
| New | +$56K |
|
3303
SurgePays
SURG
$5.48M
| $87.9K | ﹤0.01% |
49,400
+15,000
| +44% | +$26.4K |
|
3304
Fathom Holdings
FTHM
$26.4M
| $87.7K | ﹤0.01% |
57,300
+2,600
| +5% | +$5.66K |
|
|
GURE
3305
Gulf Resources
GURE
$4.65M
| $86.9K | ﹤0.01% |
15,317
-152
| -1% | -$1.04K |
|
|
QNRX
3306
Quoin Pharmaceuticals
QNRX
$8.94M
| $86.6K | ﹤0.01% |
3,803
+2,698
| +244% | +$61.9K |
|
3307
Relmada Therapeutics
RLMD
$557M
| $85.5K | ﹤0.01% |
164,513
+138,625
| +535% | +$338K |
|
3308
System1
SST
$14.3M
| $85.3K | ﹤0.01% |
9,500
+1,070
| +13% | +$10.8K |
|
|
OPTN
3309
DELISTED
OptiNose
OPTN
| $85.2K | ﹤0.01% |
12,748
-2,385
| -16% | -$21K |
|
3310
ClearSign Technologies
CLIR
$24.3M
| $84.2K | ﹤0.01% |
+5,850
| New | +$57.8K |
|
3311
Werewolf Therapeutics
HOWL
$17.2M
| $84.2K | ﹤0.01% |
56,900
-95,300
| -63% | -$194K |
|
|
KNDI
3312
Kandi Technologies Group
KNDI
$67.5M
| $83.9K | ﹤0.01% |
69,934
+22,934
| +49% | +$29.9K |
|
3313
RenovoRx
RNXT
$43.2M
| $83.7K | ﹤0.01% |
+64,900
| New | +$73.9K |
|
|
YARW
3314
Yarrow Bioscience, Inc. Common Stock
YARW
$22.4M
| $83.6K | ﹤0.01% |
499
-1,234
| -71% | -$161K |
|
|
YI
3315
111 Inc
YI
$33.9M
| $83.1K | ﹤0.01% |
13,345
-80
| -0.6% | -$624 |
|
3316
SKYX Platforms
SKYX
$147M
| $82.2K | ﹤0.01% |
+70,850
| New | +$81K |
|
|
UHG
3317
DELISTED
United Homes Group
UHG
| $81.4K | ﹤0.01% |
19,247
+555
| +3% | +$3.07K |
|
3318
Cytosorbents Corp
CTSO
$22.7M
| $80.1K | ﹤0.01% |
88,020
+8,400
| +11% | +$8.24K |
|
|
FRSX
3319
Foresight Autonomous Holdings
FRSX
$3.9M
| $78.4K | ﹤0.01% |
2,522
+572
| +29% | +$9.35K |
|
3320
PharmaCyte Biotech
PMCB
$6.18M
| $77.4K | ﹤0.01% |
49,300
-400
| -0.8% | -$690 |
|
|
SOHO
3321
DELISTED
Sotherly Hotels
SOHO
| $77.2K | ﹤0.01% |
82,914
-19,000
| -19% | -$21.1K |
|
|
FTH
3322
Faeth Therapeutics
FTH
$702M
| $76.8K | ﹤0.01% |
7,840
-2,939
| -27% | -$29.5K |
|
|
INCR
3323
Intercure
INCR
$57M
| $76.8K | ﹤0.01% |
48,300
-500
| -1% | -$787 |
|
3324
SiNtx Technologies
SINT
$10.8M
| $76.7K | ﹤0.01% |
+21,900
| New | +$73.5K |
|
|
HERE
3325
Here Group Ltd
HERE
$104M
| $76.2K | ﹤0.01% |
35,300
+900
| +3% | +$2.66K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.